
Harbin Pharmaceutical Group Co., Ltd.
SSE:600664.SS
3.81 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 16,175.856 | 15,456.578 | 13,808.761 | 12,802.016 | 10,788.457 | 11,824.562 | 10,813.614 | 12,017.531 | 14,126.886 | 15,856.208 | 16,508.913 | 18,091.935 | 17,662.947 | 13,486.96 | 12,535.44 | 10,677.301 | 9,695.068 | 8,290.27 | 9,197.584 | 8,493.389 | 7,174.9 | 6,928.744 | 6,514.94 | 5,368.314 | 6,444.458 | 4,486.974 | 2,924.758 | 2,272.71 | 2,183.241 | 2,036.429 | 1,759.251 | 2,346.04 |
Cost of Revenue
| 11,607.228 | 11,443.203 | 10,402.693 | 9,766.068 | 8,441.04 | 8,994.166 | 7,868.217 | 8,907.152 | 10,391.781 | 11,903.514 | 11,965.219 | 12,745.834 | 12,033.327 | 10,325.757 | 8,796.28 | 7,261.594 | 6,592.306 | 5,572.735 | 6,024.592 | 5,385.645 | 4,486.571 | 4,110.835 | 4,089.632 | 3,105.872 | 3,163.988 | 2,774.931 | 2,189.864 | 1,679.811 | 1,608.134 | 1,495.889 | 0 | 1,711.714 |
Gross Profit
| 4,568.628 | 4,013.375 | 3,406.068 | 3,035.947 | 2,347.416 | 2,830.395 | 2,945.397 | 3,110.379 | 3,735.105 | 3,952.694 | 4,543.693 | 5,346.1 | 5,629.62 | 3,161.203 | 3,739.159 | 3,415.706 | 3,102.762 | 2,717.535 | 3,172.992 | 3,107.744 | 2,688.329 | 2,817.909 | 2,425.308 | 2,262.441 | 3,280.47 | 1,712.043 | 734.894 | 592.899 | 575.107 | 540.54 | 1,759.251 | 634.326 |
Gross Profit Ratio
| 0.282 | 0.26 | 0.247 | 0.237 | 0.218 | 0.239 | 0.272 | 0.259 | 0.264 | 0.249 | 0.275 | 0.295 | 0.319 | 0.234 | 0.298 | 0.32 | 0.32 | 0.328 | 0.345 | 0.366 | 0.375 | 0.407 | 0.372 | 0.421 | 0.509 | 0.382 | 0.251 | 0.261 | 0.263 | 0.265 | 1 | 0.27 |
Reseach & Development Expenses
| 136.435 | 120.671 | 115.805 | 97.733 | 92.527 | 125.142 | 137.263 | 142.127 | 177.774 | 194.843 | 243.578 | 250.927 | 223.255 | 263.072 | 233.039 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 249.965 | 243.596 | 140.64 | 149.319 | 227.905 | 316.364 | 326.116 | 312.23 | 326.547 | 326.742 | 372.972 | 376.897 | 404.675 | 372.964 | 332.496 | 1,220.191 | 1,077.968 | 963.254 | 946.797 | 943.892 | 751.026 | 923.982 | 765.252 | 699.364 | 869.4 | 579.164 | 270.804 | 219.841 | 238.005 | 226.792 | 0 | 209.981 |
Selling & Marketing Expenses
| 1,950.003 | 1,717.548 | 1,753.876 | 1,327.302 | 1,075.162 | 861.284 | 619.505 | 761.022 | 762.114 | 1,131.504 | 2,303.494 | 3,137.405 | 2,846.669 | 1,121.072 | 1,243.975 | 1,083.951 | 1,000.674 | 1,094.212 | 1,445.442 | 1,351.971 | 1,509.135 | 1,329.444 | 1,153.687 | 1,077.848 | 1,962.643 | 826.248 | 203.427 | 129.873 | 94.247 | 67.116 | 0 | 83.518 |
SG&A
| 2,199.967 | 3,168.752 | 1,894.515 | 1,476.621 | 1,303.067 | 1,177.648 | 945.621 | 1,073.252 | 1,088.661 | 1,458.247 | 2,676.466 | 3,514.302 | 3,251.344 | 1,494.036 | 1,576.471 | 2,304.142 | 2,078.642 | 2,057.467 | 2,392.239 | 2,295.863 | 2,260.161 | 2,253.426 | 1,918.939 | 1,777.212 | 2,832.043 | 1,405.411 | 474.232 | 349.715 | 332.252 | 293.907 | 0 | 293.499 |
Other Expenses
| 1,342.021 | 64.323 | 735.752 | 870.123 | 1,529.517 | 1,278.595 | 60.355 | 2.881 | 89.207 | 67.632 | 30.356 | 86.437 | -82.285 | 70.369 | 40.872 | 21.302 | 127.317 | 10.559 | 12.002 | -6.308 | -7.355 | -13.594 | -9.939 | -4.14 | 22.677 | 2.376 | 15.647 | 5.32 | 8.334 | 0.898 | 2.641 | 3.698 |
Operating Expenses
| 3,678.424 | 3,392.178 | 2,746.073 | 2,444.477 | 2,925.11 | 2,581.385 | 2,396.997 | 2,513.755 | 2,661.448 | 3,040.253 | 4,064.846 | 4,948.613 | 4,691.522 | 2,534.716 | 2,559.696 | 2,373.524 | 2,136.928 | 2,102.091 | 2,453.528 | 2,355.78 | 2,320.972 | 2,312.548 | 1,970.903 | 1,818.343 | 2,900.332 | 1,442.876 | 492.365 | 363.647 | 347.267 | 306.445 | 2.641 | 391.146 |
Operating Income
| 890.205 | 659.629 | 695.803 | 642.413 | -577.694 | 602.84 | 527.371 | 655.904 | 966.34 | 741.306 | 340.101 | 237.979 | 909.747 | 682.184 | 1,290.876 | 1,083.652 | 973.263 | 616.571 | 689.404 | 670.341 | 356.15 | 472.274 | 417.933 | 399.728 | 333.917 | 215.678 | 153.988 | 140.182 | 130.744 | 131.023 | 116.555 | 161.202 |
Operating Income Ratio
| 0.055 | 0.043 | 0.05 | 0.05 | -0.054 | 0.051 | 0.049 | 0.055 | 0.068 | 0.047 | 0.021 | 0.013 | 0.052 | 0.051 | 0.103 | 0.101 | 0.1 | 0.074 | 0.075 | 0.079 | 0.05 | 0.068 | 0.064 | 0.074 | 0.052 | 0.048 | 0.053 | 0.062 | 0.06 | 0.064 | 0.066 | 0.069 |
Total Other Income Expenses Net
| -15.199 | -9.09 | 5.351 | -11.879 | -26.54 | 29.306 | 60.355 | 2.881 | 56.34 | 44.901 | 26.385 | 61.328 | -97.886 | -435.107 | 143.996 | 3.196 | 111.767 | 7.562 | -78.252 | -101.333 | -23.639 | -21.016 | -12.501 | -5.845 | 1.372 | 0.577 | -26.635 | 2.366 | 1.664 | -0.879 | 2.641 | -0.101 |
Income Before Tax
| 875.006 | 650.54 | 701.154 | 630.534 | -968.648 | 307.049 | 587.726 | 658.785 | 1,053.233 | 786.207 | 366.486 | 299.306 | 811.861 | 701.519 | 1,314.185 | 1,086.848 | 1,085.03 | 624.133 | 670.811 | 647.059 | 332.511 | 451.258 | 405.432 | 393.883 | 345.737 | 216.255 | 163.066 | 142.548 | 132.408 | 130.143 | 119.196 | 161.101 |
Income Before Tax Ratio
| 0.054 | 0.042 | 0.051 | 0.049 | -0.09 | 0.026 | 0.054 | 0.055 | 0.075 | 0.05 | 0.022 | 0.017 | 0.046 | 0.052 | 0.105 | 0.102 | 0.112 | 0.075 | 0.073 | 0.076 | 0.046 | 0.065 | 0.062 | 0.073 | 0.054 | 0.048 | 0.056 | 0.063 | 0.061 | 0.064 | 0.068 | 0.069 |
Income Tax Expense
| 184.398 | 176.322 | 190.065 | 220.689 | 76.602 | 185.18 | 184.091 | 194.421 | 209.437 | 171.727 | 168.803 | 162.777 | 221.829 | 120.3 | 181.478 | 153.255 | 221.377 | 31.879 | 95.649 | 108.162 | 59.68 | 100.687 | 94.877 | 101.445 | 116.666 | 56.999 | 29.567 | 21.603 | 19.826 | 20.097 | 18.189 | 23.663 |
Net Income
| 628.847 | 395.263 | 465.15 | 371.084 | -1,045.25 | 121.868 | 346.14 | 406.976 | 788.103 | 580.133 | 247.106 | 168.669 | 499.645 | 578.659 | 1,130.245 | 932.929 | 862.32 | 591.807 | 461.606 | 456.152 | 262.961 | 331.366 | 301.84 | 283.8 | 228.063 | 157.914 | 133.331 | 120.631 | 112.436 | 109.211 | 100.91 | 137.438 |
Net Income Ratio
| 0.039 | 0.026 | 0.034 | 0.029 | -0.097 | 0.01 | 0.032 | 0.034 | 0.056 | 0.037 | 0.015 | 0.009 | 0.028 | 0.043 | 0.09 | 0.087 | 0.089 | 0.071 | 0.05 | 0.054 | 0.037 | 0.048 | 0.046 | 0.053 | 0.035 | 0.035 | 0.046 | 0.053 | 0.051 | 0.054 | 0.057 | 0.059 |
EPS
| 0.25 | 0.16 | 0.18 | 0.15 | -0.42 | 0.044 | 0.14 | 0.16 | 0.32 | 0.23 | 0.1 | 0.069 | 0.2 | 0.35 | 0.54 | 0.44 | 0.41 | 0.28 | 0.22 | 0.22 | 0.13 | 0.16 | 0.14 | 0.14 | 0.12 | 0.078 | 0.064 | 0.08 | 0.087 | 0.084 | 0.078 | 0.11 |
EPS Diluted
| 0.25 | 0.16 | 0.18 | 0.15 | -0.42 | 0.044 | 0.14 | 0.16 | 0.31 | 0.23 | 0.1 | 0.069 | 0.2 | 0.35 | 0.54 | 0.44 | 0.41 | 0.28 | 0.22 | 0.22 | 0.13 | 0.16 | 0.14 | 0.14 | 0.12 | 0.078 | 0.064 | 0.08 | 0.087 | 0.084 | 0.078 | 0.11 |
EBITDA
| 1,223.302 | 1,011.205 | 1,121.991 | 1,067.815 | -378.696 | 769.487 | 1,050.61 | 1,129.077 | 1,536.516 | 1,280.712 | 795.222 | 760.047 | 1,250.076 | 1,187.594 | 1,661.747 | 1,358.698 | 1,434.687 | 1,043.798 | 1,122.177 | 1,093.977 | 713.415 | 791.954 | 702.711 | 637.393 | 548.872 | 434.674 | 335.189 | 229.252 | 227.84 | 234.095 | 1,759.251 | 243.18 |
EBITDA Ratio
| 0.076 | 0.065 | 0.081 | 0.083 | -0.035 | 0.065 | 0.097 | 0.094 | 0.109 | 0.081 | 0.048 | 0.042 | 0.071 | 0.088 | 0.133 | 0.127 | 0.148 | 0.126 | 0.122 | 0.129 | 0.099 | 0.114 | 0.108 | 0.119 | 0.085 | 0.097 | 0.115 | 0.101 | 0.104 | 0.115 | 1 | 0.104 |